Correlation Between ZyVersa Therapeutics and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Immix Biopharma, you can compare the effects of market volatilities on ZyVersa Therapeutics and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Immix Biopharma.
Diversification Opportunities for ZyVersa Therapeutics and Immix Biopharma
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between ZyVersa and Immix is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Immix Biopharma go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Immix Biopharma
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to generate 2.16 times more return on investment than Immix Biopharma. However, ZyVersa Therapeutics is 2.16 times more volatile than Immix Biopharma. It trades about 0.18 of its potential returns per unit of risk. Immix Biopharma is currently generating about -0.15 per unit of risk. If you would invest 109.00 in ZyVersa Therapeutics on November 3, 2024 and sell it today you would earn a total of 29.02 from holding ZyVersa Therapeutics or generate 26.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Immix Biopharma
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Immix Biopharma |
ZyVersa Therapeutics and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Immix Biopharma
The main advantage of trading using opposite ZyVersa Therapeutics and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |